parkinson's disease retatrutide clinical trial A CT man with a life-altering is first in Glucagon-like peptide-1 class drugs show

One might have expected a more pronounced improvement in glycemic control, given the degree of weight reduction, he says

Always start low (e.g., 0.25 mg for Wegovy) and increase slowly, typically every 4 weeks, only if you are comfortable

Study procedure (Koide et al., 2025) GLP-1RA therapy significantly reduced blood glucose levels, body weight, and body fat percentage Results showed that after 12 months of treatment, GLP-1RA therapy significantly reduced participants blood glucose levels (as measured by glycated hemoglobin), body weight, and body fat percentage

Journal of the International Society of Sports Nutrition